Editorial
Prognosis of neuropathy with monoclonal gammopathy
Norman Latov MD, PhD,
Corresponding Author
Norman Latov MD, PhD
Department of Neurology, Columbia University, 710 W. 168th Street, New York, New York 10032, USA
Department of Neurology, Columbia University, 710 W. 168th Street, New York, New York 10032, USASearch for more papers by this authorNorman Latov MD, PhD,
Corresponding Author
Norman Latov MD, PhD
Department of Neurology, Columbia University, 710 W. 168th Street, New York, New York 10032, USA
Department of Neurology, Columbia University, 710 W. 168th Street, New York, New York 10032, USASearch for more papers by this authorFirst published: 18 January 2000
Citations: 23
No abstract is available for this article.
REFERENCES
- 1Axelsson U. A 20 year follow-up study of 64 subjects with M-components. Acta Med Scand 1986; 219; 519–522.
- 2Ellie E, Vital A, Steck A, Boiron J-M, Vital C, Julien J. Neuropathy associated with “benign” anti-myelin associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiologic, and pathological findings, and response to treatment in 33 cases. J Neurol 1996; 243: 34–43.
- 3Gorson KC, Ropper AH. Axonal neuropathy associated with monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry 1997; 63: 163–168.
- 4Kahn SN, Riches PG, Kohn J. Paraproteinemia in neurologic disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 1980; 33: 617–621
- 5Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ. Prevalence of monoclonal proteins in peripheral neuropathy. Neurology 1981; 31: 1480–1483.
- 6Kelly JJ, Adelman LS, Berkman E, Bhan I. Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 1988; 45: 1355–1359.
- 7Krol-V Straaten MJ, Ackerstaff RGA, de Maat CEM. Peripheral neuropathy and monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry 1985; 48: 706–708.
- 8Kyle RA. “Benign” monoclonal gammopathy − after 20 to 35 years of follow-up. Mayo Clin Proc 1993; 68: 26–36
- 9Latov N, Hays AP, Sherman WH. Peripheral neuropathy and anti-MAG antibodies. CRC Crit Rev Neurobiol 1988; 3: 301–332.
- 10Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, Premoselli S, Manfredini E, Scarlato G. Peripheral neuropathy in monoclonal gammopathy of undetermined significance;prevalence and immunopathogenic studies. Acta Neurol Scand 1992; 85: 383–390.
- 11Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L, Sgarzi M, Scarlato G. Frequency and clinical correlates of anti-neural igM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994; 36: 416–424.
- 12Nottermans NC, Wokke JHJ, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FGI. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994; 117: 1385–1393.
- 13Ponsford S, Willison H, Veitch J, Morris R, Thomas PK. Long term clinical and neurophysiological follow-up of patients with peripheral neuropathy associated with benign monoclonal gammopathy. Muscle Nerve 2000; 23: 164–174.
10.1002/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y Google Scholar
- 14Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia. A clinical and neurophysiological study. Brain 1994; 117: 949–957.
- 15Van den Berg LH, Hays AP, Nobile-Orazio E, Kinsella LJ, Manfredini E, Corbo M, Rosoklija G, Younger DS, Lovelace RE, Trojaborg W, Lange DE, Goldstein S, Delfiner JS, Sadiq SA, Sherman WH, Latov N. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 1996; 19: 637–43.
10.1002/(SICI)1097-4598(199605)19:5<637::AID-MUS12>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 16Vital A, Vital C, Julien J, Baquey A, Steck AJ. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol 1989; 79: 160–167.
Citing Literature
